C17orf37 antibody
Principal name
C17orf37 antibody
Alternative names for C17orf37 antibody
Protein C35, XTP4, Uncharacterized protein C17orf37, HBV X-transactivated gene 4 protein
Ncbi ID
9606, NP_115715, NP_115715.3, NP_079835.1, NM_025559, NM_032339
Available reactivities
Available hosts
Available applications
ELISA (detection) (E(detection)), Western blot / Immunoblot (WB), Enzyme Immunoassay (E), Immunoprecipitation (IP), Flow Cytometry (F), Paraffin Sections (P), Immunocytochemistry/Immunofluorescence (ICC/IF)
Background of C17orf37 antibody
The National Institutes of Health Mammalian Gene Collection (MGC) Program is a multi-institutional effort to identify and sequence a cDNA clone containing a complete ORF for each human and mouse gene. ESTs were generated from libraries enriched for full-length cDNAs and analyzed to identify candidate full-ORF clones, which then were sequenced to high accuracy. The MGC has currently sequenced and verified the full ORF for a non-redundant set of >9,000 human and >6,000 mouse genes. Candidate full-ORF clones for an additional 7,800 human and 3,500 mouse genes also have been identified. All MGC sequences and clones are available without restriction through public databases and clone distribution networks” see http:mgc.nci.nih.gov. (1).
The Chromosome 17 open reading frame 137 gene is associated with prostate cancer and functionally associated with redox related processes in cytoplasm, it belongs to the SelWTH family of proteins. The C17Orf137 is trans activated by hepatitis B virus A antigen (HVVX-transactivated). The C17Orf137 is absently expressed in breast cancer cells.
Several C3Orf34 like proteins have been analyzed and identified including HSD5. The C3Orf34 have several splice variant sites that result expression of this protein in multiple variants. The protein has several functional domains including multiple phosphoenolpyruvate carboxylase (ppc) domain in the middle of the protein. Similar to C3Orf34 a HSD5 gene (C3Orf34 like) was identified in chimpanzee with 4 extra amino acids at the N-terminal end of the protein. Recently its noted that C3Orf34 is differentially expressed in cancer cells. C3Orf34 is a 163 amino acid long protein with an apparent molecular weight of 20-22kDa in size.
General readings
Dasgupta,S., et al. (2011) J. Biol. Chem. 286 (29), 25935-25946Katz,E., et al. (2011) Anal Cell Pathol (Amst) 34 (1-2), 35-48
C17orf37 MaxPab polyclonal antibody. Western Blot analysis of C17orf37 expression in human colon.
Western Blot analysis of C17orf37 expression in transfected 293T cell line (H00084299-T01) by C17orf37 MaxPab polyclonal antibody.Lane 1: C17orf37 transfected lysate(12.65 KDa).Lane 2: Non-transfected lysate.
C17orf37 MaxPab polyclonal antibody. Western Blot analysis of C17orf37 expression in human colon.
Western Blot analysis of C17orf37 expression in transfected 293T cell line (H00084299-T01) by C17orf37 MaxPab polyclonal antibody.Lane 1: C17orf37 transfected lysate(12.65 KDa).Lane 2: Non-transfected lysate.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY C17orf37 (RC203346, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-C17orf37.
Western blot analysis of extracts (10ug) from 1 cell line by using anti-C17orf37 monoclonal antibody.(1:200)
Western blot analysis of extracts (10ug) from 2 different cell lines by using anti-C17orf37 monoclonal antibody.(1:200)
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY C17orf37 (RC203346, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-C17orf37.
Flow cytometric Analysis of Hela cells, using anti-C17orf37 antibody(TA504600),(Red), compared to a nonspecific negative control antibody,(Blue).
Flow cytometric Analysis of Jurkat cells, using anti-C17orf37 antibody(TA504600),(Red), compared to a nonspecific negative control antibody,(Blue).
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY C17orf37 (RC203346, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-C17orf37.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY C17orf37 (RC203346, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-C17orf37.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY C17orf37 (RC203346, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-C17orf37.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY C17orf37 (RC203346, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-C17orf37.
Immunohistochemical staining of paraffin-embedded Carcinoma of Human bladder tissue using anti-C17orf37 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA504626)
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY C17orf37 (RC203346, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-C17orf37.
Immunohistochemical staining of paraffin-embedded Carcinoma of Human prostate tissue using anti-C17orf37 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA800015)
Immunohistochemical staining of paraffin-embedded Human prostate tissue within the normal limits using anti-C17orf37 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA800015)
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY C17orf37 (RC203346, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-C17orf37.
HEK293T cells transfected with either RC203346 overexpress plasmid(Red) or empty vector control plasmid(Blue) were immunostained by anti-C17orf37 antibody(TA800015), and then analyzed by flow cytometry.
Anti-C17orf37 mouse monoclonal antibody (TA800016) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY C17orf37(RC203346).
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY C17orf37 (RC203346, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-C17orf37.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY C17orf37 (RC203346, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-C17orf37.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY C17orf37 (RC203346, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-C17orf37.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY C17orf37 (RC203346, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-C17orf37.
Immunohistochemical staining of paraffin-embedded Human breast tissue within the normal limits using anti-C17orf37 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA800020)
Immunohistochemical staining of paraffin-embedded Carcinoma of Human lung tissue using anti-C17orf37 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA800020)
Immunohistochemical staining of paraffin-embedded Adenocarcinoma of Human ovary tissue using anti-C17orf37 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA800020)
Immunohistochemical staining of paraffin-embedded Adenocarcinoma of Human endometrium tissue using anti-C17orf37 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA800020)
Immunohistochemical staining of paraffin-embedded Human pancreas tissue within the normal limits using anti-C17orf37 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA800020)
Immunohistochemical staining of paraffin-embedded Carcinoma of Human prostate tissue using anti-C17orf37 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA800020)
Immunohistochemical staining of paraffin-embedded Carcinoma of Human pancreas tissue using anti-C17orf37 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA800020)
Immunohistochemical staining of paraffin-embedded Carcinoma of Human bladder tissue using anti-C17orf37 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA800020)
Immunohistochemical staining of paraffin-embedded Human lymphoma tissue using anti-C17orf37 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA800020)
Anti-C17orf37 mouse monoclonal antibody (TA800020) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY C17orf37(RC203346).
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY C17orf37 (RC203346, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-C17orf37.
Immunohistochemical staining of paraffin-embedded Carcinoma of Human thyroid tissue using anti-C17orf37 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA800021)
Immunohistochemical staining of paraffin-embedded Human liver tissue within the normal limits using anti-C17orf37 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA800021)
Immunohistochemical staining of paraffin-embedded Human Kidney tissue within the normal limits using anti-C17orf37 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA800021)
Immunohistochemical staining of paraffin-embedded Human pancreas tissue within the normal limits using anti-C17orf37 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA800021)
Immunohistochemical staining of paraffin-embedded Adenocarcinoma of Human ovary tissue using anti-C17orf37 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA800021)
Immunohistochemical staining of paraffin-embedded Carcinoma of Human prostate tissue using anti-C17orf37 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA800021)
Immunohistochemical staining of paraffin-embedded Adenocarcinoma of Human endometrium tissue using anti-C17orf37 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA800021)
Immunohistochemical staining of paraffin-embedded Human prostate tissue within the normal limits using anti-C17orf37 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA800021)
Western blot analysis of extracts (35ug) from 9 different cell lines by usin g anti-C17orf37 monoclonal antibody (HepG2: human; HeLa: human; SVT2: mouse; A549: human; COS7: monkey; Jurkat: human; MDCK: canine; PC12: rat; MCF7: human).
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY C17orf37 (RC203346, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-C17orf37.
HEK293T cells transfected with either RC203346 overexpress plasmid(Red) or empty vector control plasmid(Blue) were immunostained by anti-C17orf37 antibody(TA800021), and then analyzed by flow cytometry.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY C17orf37 (RC203346, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-C17orf37.
HEK293T cells transfected with either RC203346 overexpress plasmid(Red) or empty vector control plasmid(Blue) were immunostained by anti-C17orf37 antibody(TA800022), and then analyzed by flow cytometry.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY C17orf37 (RC203346, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-C17orf37.
HEK293T cells transfected with either RC203346 overexpress plasmid(Red) or empty vector control plasmid(Blue) were immunostained by anti-C17orf37 antibody(TA800023), and then analyzed by flow cytometry.
- Quick-Filters:
- Highly Validated (4)
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA504600 | C17orf37 antibody |
||||||
| C17orf37 (XTP4) mouse monoclonal antibody, clone OTI1E8 (formerly 1E8) | |||||||
 |
Mouse | IgG2a | OTI1E8 | Purified | Hu | F, WB |
0.1 ml /
€350.00
|
| OriGene Technologies, Inc. | |||||||
 +3 additional images |
Highly validated antibody!
|
||||||
| TA800015 | C17orf37 antibody |
||||||
| C17orf37 (XTP4) mouse monoclonal antibody, clone OTI4D4 (formerly 4D4) | |||||||
 |
Mouse | IgG2a | OTI4D4 | Purified | Hu | F, P, WB |
0.1 ml /
€350.00
|
| OriGene Technologies, Inc. | |||||||
| +3 additional images |
Highly validated antibody!
|
||||||
| TA800020 | C17orf37 antibody |
||||||
| C17orf37 (XTP4) mouse monoclonal antibody, clone OTI2D5 (formerly 2D5) | |||||||
 |
Mouse | IgG2b | OTI2D5 | Purified | Hu | ICC/IF, P, WB |
0.1 ml /
€350.00
|
| OriGene Technologies, Inc. | |||||||
| +10 additional images |
Highly validated antibody!
|
||||||
| TA800021 | C17orf37 antibody |
||||||
| C17orf37 (XTP4) mouse monoclonal antibody, clone OTI2D2 (formerly 2D2) | |||||||
 |
Mouse | IgG1 | OTI2D2 | Purified | Can, Hu, Mky, Ms, Rt | F, P, WB |
0.1 ml /
€379.00
|
| OriGene Technologies, Inc. | |||||||
| +10 additional images |
Highly validated antibody!
|
||||||
| TA504583 | C17orf37 antibody |
||||||
| C17orf37 (XTP4) mouse monoclonal antibody, clone OTI1D7 (formerly 1D7) | |||||||
 |
Mouse | IgG1 | OTI1D7 | Purified | Hu | WB |
0.1 ml /
€350.00
|
| OriGene Technologies, Inc. | |||||||
| +1 additional image |
|
||||||
| TA504609 | C17orf37 antibody |
||||||
| C17orf37 (XTP4) mouse monoclonal antibody, clone OTI1E4 (formerly 1E4) | |||||||
 |
Mouse | IgG2b | OTI1E4 | Purified | Hu | WB |
0.1 ml /
€350.00
|
| OriGene Technologies, Inc. | |||||||
|
|||||||
| TA504613 | C17orf37 antibody |
||||||
| C17orf37 (XTP4) mouse monoclonal antibody, clone OTI1E1 (formerly 1E1) | |||||||
 |
Mouse | IgG1 | OTI1E1 | Purified | Hu | WB |
0.1 ml /
€350.00
|
| OriGene Technologies, Inc. | |||||||
|
|||||||
| TA504614 | C17orf37 antibody |
||||||
| C17orf37 (XTP4) mouse monoclonal antibody, clone OTI1G2 (formerly 1G2) | |||||||
 |
Mouse | IgG1 | OTI1G2 | Purified | Hu | WB |
0.1 ml /
€350.00
|
| OriGene Technologies, Inc. | |||||||
|
|||||||
| TA504625 | C17orf37 antibody |
||||||
| C17orf37 (XTP4) mouse monoclonal antibody, clone OTI4D6 (formerly 4D6) | |||||||
 |
Mouse | IgG1 | OTI4D6 | Purified | Hu | WB |
0.1 ml /
€350.00
|
| OriGene Technologies, Inc. | |||||||
|
|||||||
| TA504626 | C17orf37 antibody |
||||||
| C17orf37 (XTP4) mouse monoclonal antibody, clone OTI1D4 (formerly 1D4) | |||||||
 |
Mouse | IgG1 | OTI1D4 | Purified | Hu | P, WB |
0.1 ml /
€350.00
|
| OriGene Technologies, Inc. | |||||||
| +1 additional image |
|
||||||
| TA800016 | C17orf37 antibody |
||||||
| C17orf37 (XTP4) mouse monoclonal antibody, clone OTI3D12 (formerly 3D12) | |||||||
 |
Mouse | IgG1 | OTI3D12 | Purified | Hu | ICC/IF, WB |
0.1 ml /
€350.00
|
| OriGene Technologies, Inc. | |||||||
| +1 additional image |
|
||||||
| TA800017 | C17orf37 antibody |
||||||
| C17orf37 (XTP4) mouse monoclonal antibody, clone OTI3D9 (formerly 3D9) | |||||||
 |
Mouse | IgG1 | OTI3D9 | Purified | Hu | WB |
0.1 ml /
€350.00
|
| OriGene Technologies, Inc. | |||||||
|
|||||||
| TA800018 | C17orf37 antibody |
||||||
| C17orf37 (XTP4) mouse monoclonal antibody, clone OTI3H9 (formerly 3H9) | |||||||
 |
Mouse | IgG1 | OTI3H9 | Purified | Hu | WB |
0.1 ml /
€350.00
|
| OriGene Technologies, Inc. | |||||||
|
|||||||
| TA800019 | C17orf37 antibody |
||||||
| C17orf37 (XTP4) mouse monoclonal antibody, clone OTI1A3 (formerly 1A3) | |||||||
 |
Mouse | IgG1 | OTI1A3 | Purified | Hu | WB |
0.1 ml /
€350.00
|
| OriGene Technologies, Inc. | |||||||
|
|||||||
| TA800022 | C17orf37 antibody |
||||||
| C17orf37 (XTP4) mouse monoclonal antibody, clone OTI3D2 (formerly 3D2) | |||||||
 |
Mouse | IgG1 | OTI3D2 | Purified | Hu | F, WB |
0.1 ml /
€350.00
|
| OriGene Technologies, Inc. | |||||||
| +1 additional image |
|
||||||
| TA800023 | C17orf37 antibody |
||||||
| C17orf37 (XTP4) mouse monoclonal antibody, clone OTI2D4 (formerly 2D4) | |||||||
 |
Mouse | IgG1 | OTI2D4 | Purified | Hu | F, WB |
0.1 ml /
€350.00
|
| OriGene Technologies, Inc. | |||||||
| +1 additional image |
|
||||||
CRISPR
| Catalog No. | Species | Donor Vector | |
|---|---|---|---|
| KN203346 | MIEN1 - human gene knockout kit via CRISPR |
||
 |
Human | GFP-Puro |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN203346BN | MIEN1 - human gene knockout kit via CRISPR |
||
|
Human | mBFP-Neo |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN203346LP | MIEN1 - human gene knockout kit via CRISPR |
||
|
Human | Luciferase-Puro |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN203346RB | MIEN1 - human gene knockout kit via CRISPR |
||
|
Human | RFP-BSD |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
